Timing of Chemotherapy for Glioblastoma May Matter
Treatment in the morning may be more effective, with greater impact seen in MGMT-methylated patients
Opdivo Plus Chemotherapy Approved for Treatment of Gastric Cancer
FDA granted Opdivo first approval of immunotherapy for first-line treatment of advanced or metastatic gastric cancer
Proportion of Black Physicians Has Changed Little Since 1900
Racial income differences were statistically significant each survey year, with difference of $50,000 in 2018
J&J COVID-19 Vaccine Should Be Used, but Carry Blood Clot Warning
European Medicines Agency also said the vaccine's benefits still far outweigh its risks
Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy
Cutaneous immune-related adverse events seen in 25 percent of cancer patients initiating ICI therapy with median onset time of 113 days
Children With Down Syndrome at Higher Risk for Leukemia
Risk particularly high for acute myeloid leukemia before age 5 years
Biden Administration Lifts Restrictions on Medical Research Using Fetal Tissues
All projects that had been approved before the Trump administration restrictions 'will be reinstated without further review'
Grandmaternal DDT Exposure Tied to Granddaughter Early Menarche, Obesity
o,p'-DDT exposure in normal-weight, but not overweight or obese, grandmothers linked to obesity in granddaughters
Risk-Based Approach Developed to Triage Mammography Use
Clinical indication and individual risk factors linked to breast cancer detection and could help triage mammography use
Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common
About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects
